Pages that link to "Q35650030"

The following pages link to Passive protection of diabetic rats with antisera specific for the polysaccharide portion of the lipopolysaccharide isolated from Pseudomonas pseudomallei (Q35650030):

Displaying 37 items.

• Melioidosis: epidemiology, pathophysiology, and management (Q24522461) (← links)
• Development of Burkholderia mallei and pseudomallei vaccines (Q26861271) (← links)
• From crystal structure to in silico epitope discovery in the Burkholderia pseudomallei flagellar hook-associated protein FlgK (Q27697853) (← links)
• Recombinant Salmonella Expressing Burkholderia mallei LPS O Antigen Provides Protection in a Murine Model of Melioidosis and Glanders (Q30279061) (← links)
• Detection of bacterial virulence genes by subtractive hybridization: identification of capsular polysaccharide of Burkholderia pseudomallei as a major virulence determinant (Q30635403) (← links)
• Current studies on the pathogenesis of melioidosis (Q33792578) (← links)
• The capsular polysaccharide of Burkholderia pseudomallei contributes to survival in serum by reducing complement factor C3b deposition (Q33798900) (← links)
• Pathogenesis of and immunity to melioidosis (Q33837734) (← links)
• Lipopolysaccharide from Nonvirulent Ara Burkholderia pseudomallei Isolates Is Immunologically Indistinguishable from Lipopolysaccharide from Virulent Ara − Clinical Isolates (Q33991815) (← links)
• Humoral and cell-mediated adaptive immune responses are required for protection against Burkholderia pseudomallei challenge and bacterial clearance postinfection. (Q34034124) (← links)
• Burkholderia pseudomallei capsular polysaccharide conjugates provide protection against acute melioidosis (Q34058969) (← links)
• Polysaccharide specific monoclonal antibodies provide passive protection against intranasal challenge with Burkholderia pseudomallei (Q34243707) (← links)
• Monoclonal antibodies passively protect BALB/c mice against Burkholderia mallei aerosol challenge (Q34491887) (← links)
• Burkholderia thailandensis oacA mutants facilitate the expression of Burkholderia mallei-like O polysaccharides (Q34529504) (← links)
• Use of a safe, reproducible, and rapid aerosol delivery method to study infection by Burkholderia pseudomallei and Burkholderia mallei in mice (Q35009671) (← links)
• Characterization of the capsular polysaccharide of Burkholderia (Pseudomonas) pseudomallei 304b (Q35630032) (← links)
• Fate of a Burkholderia pseudomallei lipopolysaccharide mutant in the mouse macrophage cell line RAW 264.7: possible role for the O-antigenic polysaccharide moiety of lipopolysaccharide in internalization and intracellular survival (Q38637308) (← links)
• Detailed structural analysis of the O-polysaccharide expressed by Burkholderia thailandensis E264. (Q36392951) (← links)
• Development of novel O-polysaccharide based glycoconjugates for immunization against glanders (Q36424795) (← links)
• Burkholderia vaccines: are we moving forward? (Q36587103) (← links)
• Contribution of murine IgG Fc regions to antibody binding to the capsule of Burkholderia pseudomallei (Q37189868) (← links)
• Correlates of immune protection following cutaneous immunization with an attenuated Burkholderia pseudomallei vaccine. (Q37336008) (← links)
• Protective response to subunit vaccination against intranasal Burkholderia mallei and B. pseudomallei challenge. (Q37417238) (← links)
• Revised structures for the predominant O-polysaccharides expressed by Burkholderia pseudomallei and Burkholderia mallei (Q37582243) (← links)
• The molecular and cellular basis of pathogenesis in melioidosis: how does Burkholderia pseudomallei cause disease? (Q37592283) (← links)
• Deciphering minimal antigenic epitopes associated with Burkholderia pseudomallei and Burkholderia mallei lipopolysaccharide O-antigens (Q38287677) (← links)
• Burkholderia pseudomallei and Burkholderia mallei vaccines: Are we close to clinical trials? (Q39197155) (← links)
• Isolation of polymyxin B-susceptible mutants of Burkholderia pseudomallei and molecular characterization of genetic loci involved in polymyxin B resistance. (Q39472156) (← links)
• Molecular and physical characterization of Burkholderia mallei O antigens (Q39694495) (← links)
• Lipopolysaccharide from Burkholderia thailandensis E264 provides protection in a murine model of melioidosis (Q42908999) (← links)
• Characterization of the type III capsular polysaccharide produced by Burkholderia pseudomallei (Q42931903) (← links)
• Burkholderia pseudomallei: animal models of infection (Q44023136) (← links)
• The type II O-antigenic polysaccharide moiety of Burkholderia pseudomallei lipopolysaccharide is required for serum resistance and virulence (Q44760968) (← links)
• Development of Subunit Vaccines that Provide High Level Protection and Sterilizing Immunity Against Acute Inhalational Melioidosis (Q47130468) (← links)
• Burkholderia pseudomallei kills the nematode Caenorhabditis elegans using an endotoxin-mediated paralysis. (Q52543308) (← links)
• Protective efficacy of heat-inactivated B. thailandensis, B. mallei or B. pseudomallei against experimental melioidosis and glanders (Q57942331) (← links)
• Shedding of lipopolysaccharide and 200-kDa surface antigen during the in vitro growth of virulent Ara- and avirulent Ara Burkholderia pseudomallei (Q73448149) (← links)